Role of high mobility group box 1 in inflammatory disease: Focus on sepsis

Archives of Pharmacal Research

Volumn 35, Issue 9, 2012, Pages 1511-1523

  Bae, Jong Sup ^a  

^a Kyungpook National University   (South Korea)

Author keywords

HMGB1; HMGB1 inhibitor; Infection; LPS; Sepsis

Indexed keywords

ANTITHROMBIN; ANTITHROMBIN III; CURCUMIN; ENDOTOXIN; EPIGALLOCATECHIN GALLATE; GAMMA INTERFERON ANTIBODY; GHRELIN; HEPARIN; HERBACEOUS AGENT; HIGH MOBILITY GROUP B1 PROTEIN; HORMONE; IMMUNOGLOBULIN; KAEMPFEROL 3 SOPHOROSIDE; LYCOPENE; MEIZOTHROMBIN; OLEANOLIC ACID; PHLOROTANNIN DERIVATIVE; RECOMBINANT HIGH MOBILITY GROUP B1 PROTEIN; RECOMBINANT PROTEIN; RECOMBINANT THROMBOMODULIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; WITHAFERIN A;

ATHEROSCLEROSIS; CELL MIGRATION; CELLULAR IMMUNITY; CHEMOTAXIS; CHINESE MEDICINE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TARGETING; DRUG TREATMENT FAILURE; ENDOTOXEMIA; HEART INFARCTION; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INFLAMMATORY DISEASE; INTRACELLULAR SIGNALING; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SEPSIS; SEPTIC SHOCK; SHOCK; SIGNAL TRANSDUCTION; VASCULAR DISEASE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUGS, INVESTIGATIONAL; HMGB1 PROTEIN; HUMANS; MACROPHAGES; MOLECULAR TARGETED THERAPY; MONOCYTES; RECEPTORS, IMMUNOLOGIC; SEPSIS; TOLL-LIKE RECEPTORS;

EID: 84870562887     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-012-0901-5     Document Type: Review

References (88)

1. Abeyama, K., Stern, D. M., Ito, Y., Kawahara, K., Yoshimoto, Y., Tanaka, M., Uchimura, T., Ida, N., Yamazaki, Y., Yamada, S., Yamamoto, Y., Yamamoto, H., Iino, S., Taniguchi, N., and Maruyama, I., The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J. Clin. Invest., 115, 1267-1274 (2005).
2. Abraham, E., Arcaroli, J., Carmody, A., Wang, H., and Tracey, K. J., HMG-1 as a mediator of acute lung inflammation. J. Immunol., 165, 2950-2954 (2000a).
3. Abraham, E., Matthay, M. A., Dinarello, C. A., Vincent, J. L., Cohen, J., Opal, S. M., Glauser, M., Parsons, P., Fisher, C. J., Jr., and Repine, J. E., Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit. Care Med., 28, 232-235 (2000b).
4. Abraham, E., Reinhart, K., Opal, S., Demeyer, I., Doig, C., Rodriguez, A. L., Beale, R., Svoboda, P., Laterre, P. F., Simon, S., Light, B., Spapen, H., Stone, J., Seibert, A., Peckelsen, C., De Deyne, C., Postier, R., Pettila, V., Artigas, A., Percell, S. R., Shu, V., Zwingelstein, C., Tobias, J., Poole, L., Stolzenbach, J. C., and Creasey, A. A., Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA, 290, 238-247 (2003).
5. Agnello, D., Wang, H., Yang, H., Tracey, K. J., and Ghezzi, P., HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine, 18, 231-236 (2002).
6. Andersson, U. and Tracey, K. J., HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol., 29, 139-162 (2011).
7. Andersson, U., Wang, H., Palmblad, K., Aveberger, A. C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., and Tracey, K. J., High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med., 192, 565- 570 (2000).
8. Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., Yang, H., Amigorena, S., Ryffel, B., Barrat, F. J., Saftig, P., Levi, F., Lidereau, R., Nogues, C., Mira, J. P., Chompret, A., Joulin, V., Clavel-Chapelon, F., Bourhis, J., Andre, F., Delaloge, S., Tursz, T., Kroemer, G., and Zitvogel, L., Tolllike receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med., 13, 1050-1059 (2007).
9. Bae, J. S. and Rezaie, A. R., Activated protein C inhibits high mobility group box 1 signaling in endothelial cells. Blood, 118, 3952-3959 (2011).
10. Bae, J. W. and Bae, J. S., Barrier protective effects of lycopene in human endothelial cells. Inflamm. Res., 60, 751-758 (2011).
11. Baggiolini, M. and Loetscher, P., Chemokines in inflammation and immunity. Immunol. Today, 21, 418-420 (2000).
12. Bell, C. W., Jiang, W., Reich, C. F., 3rd, and Pisetsky, D. S., The extracellular release of HMGB1 during apoptotic cell death. Am. J. Physiol. Cell Physiol., 291, C1318-C1325 (2006).
13. Bernard, G. R., Vincent, J. L., Laterre, P. F., Larosa, S. P., Dhainaut, J. F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., and Fisher, C. J., Jr., Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med., 344, 699-709 (2001).
14. Brightbill, H. D., Libraty, D. H., Krutzik, S. R., Yang, R. B., Belisle, J. T., Bleharski, J. R., Maitland, M., Norgard, M. V., Plevy, S. E., Smale, S. T., Brennan, P. J., Bloom, B. R., Godowski, P. J., and Modlin, R. L., Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science, 285, 732-736 (1999).
15. Britton, G., Structure and properties of carotenoids in relation to function. FASEB J., 9, 1551-1558 (1995).
16. Chacur, M., Milligan, E. D., Gazda, L. S., Armstrong, C., Wang, H., Tracey, K. J., Maier, S. F., and Watkins, L. R., A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats. Pain, 94, 231-244 (2001).
17. Chen, C. J., Kono, H., Golenbock, D., Reed, G., Akira, S., and Rock, K. L., Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med., 13, 851-856 (2007).
18. Chorny, A. and Delgado, M., Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1. Am. J. Pathol., 172, 1297-1307 (2008).
19. Degryse, B., Bonaldi, T., Scaffidi, P., Muller, S., Resnati, M., Sanvito, F., Arrigoni, G., and Bianchi, M. E., The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol., 152, 1197-1206 (2001).
20. Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., Calandra, T., Dhainaut, J. F., Gerlach, H., Harvey, M., Marini, J. J., Marshall, J., Ranieri, M., Ramsay, G., Sevransky, J., Thompson, B. T., Townsend, S., Vender, J. S., Zimmerman, J. L., and Vincent, J. L., Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med., 36, 296-327 (2008).
21. Essawi, T. and Srour, M., Screening of some Palestinian medicinal plants for antibacterial activity. J. Ethnopharmacol., 70, 343-349 (2000).
22. Faraco, G., Fossati, S., Bianchi, M. E., Patrone, M., Pedrazzi, M., Sparatore, B., Moroni, F., and Chiarugi, A., High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J. Neurochem., 103, 590-603 (2007).
23. Ferrari, S., Finelli, P., Rocchi, M., and Bianchi, M. E., The active gene that encodes human high mobility group 1 protein (HMG1) contains introns and maps to chromosome 13. Genomics, 35, 367-371 (1996).
24. Fiuza, C., Bustin, M., Talwar, S., Tropea, M., Gerstenberger, E., Shelhamer, J. H., and Suffredini, A. F., Inflammationpromoting activity of HMGB1 on human microvascular endothelial cells. Blood, 101, 2652-2660 (2003).
25. Hagiwara, S., Iwasaka, H., Hasegawa, A., Asai, N., and Noguchi, T., High-dose intravenous immunoglobulin G improves systemic inflammation in a rat model of CLP-induced sepsis. Intensive Care Med., 34, 1812-1819 (2008a).
26. Hagiwara, S., Iwasaka, H., Hasegawa, A., Koga, H., and Noguchi, T., Effects of hyperglycemia and insulin therapy on high mobility group box 1 in endotoxin-induced acute lung injury in a rat model. Crit. Care Med., 36, 2407-2413 (2008b).
27. Hagiwara, S., Iwasaka, H., Matsumoto, S., and Noguchi, T., High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats. Intensive Care Med., 34, 361-367 (2008c).
28. Hatada, T., Wada, H., Nobori, T., Okabayashi, K., Maruyama, K., Abe, Y., Uemoto, S., Yamada, S., and Maruyama, I., Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb. Haemost., 94, 975-979 (2005).
29. Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., Morser, J., Stern, D., and Schmidt, A. M., The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and coexpression of rage and amphoterin in the developing nervous system. J. Biol. Chem., 270, 25752-25761 (1995).
30. Huttunen, H. J., Fages, C., Kuja-Panula, J., Ridley, A. J., and Rauvala, H., Receptor for advanced glycation end productsbinding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res., 62, 4805- 4811 (2002).
31. Ivanov, S., Dragoi, A. M., Wang, X., Dallacosta, C., Louten, J., Musco, G., Sitia, G., Yap, G. S., Wan, Y., Biron, C. A., Bianchi, M. E., Wang, H., and Chu, W. M., A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood, 110, 1970-1981 (2007).
32. Kaileh, M., Vanden Berghe, W., Heyerick, A., Horion, J., Piette, J., Libert, C., De Keukeleire, D., Essawi, T., and Haegeman, G., Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity. J. Biol. Chem., 282, 4253-4264 (2007).
33. Kim, D. C., Lee, W., and Bae, J. S., Vascular anti-inflammatory effects of curcumin on HMGB1-mediated responses in vitro. Inflamm Res., 60, 1161-1168 (2011).
34. Kim, T. H., Ku, S.-K., and Bae, J.-S., Effects of (-)-epigallocatechin gallate on either HMGB1 or IL-1beta-mediated barrier disruption in human endothelial cells. Journal of The Korean Society for Applied Biological Chemistry, 55, 165-173 (2012a).
35. Kim, T. H., Ku, S. K., and Bae, J. S., Inhibitory effects of kaempferol-3-O-sophoroside on HMGB1-mediated proinflammatory responses. Food Chem. Toxicol., 50, 1118- 1123 (2012b).
36. Kim, T. H., Ku, S. K., Lee, T., and Bae, J. S., Vascular barrier protective effects of phlorotannins on HMGB1-mediated proinflammatory responses in vitro and in vivo. Food Chem. Toxicol., 50, 2188-2195 (2012c).
37. Kokkola, R., Li, J., Sundberg, E., Aveberger, A. C., Palmblad, K., Yang, H., Tracey, K. J., Andersson, U., and Harris, H. E., Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum., 48, 2052-2058 (2003).
38. Kornblit, B., Munthe-Fog, L., Madsen, H. O., Strom, J., Vindelov, L., and Garred, P., Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome. Crit. Care, 12, R83 (2008).
39. Lee, W., Kim, T. H., Ku, S. K., Min, K. J., Lee, H. S., Kwon, T. K., and Bae, J. S., Barrier protective effects of withaferin A in HMGB1-induced inflammatory responses in both cellular and animal models. Toxicol. Appl. Pharmacol., 262, 91-98 (2012a).
40. Lee, W., Ku, S. K., Bae, J. W., and Bae, J. S., Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models. Food Chem. Toxicol., 50, 1826-1833 (2012b).
41. Li, J., Kokkola, R., Tabibzadeh, S., Yang, R., Ochani, M., Qiang, X., Harris, H. E., Czura, C. J., Wang, H., Ulloa, L., Warren, H. S., Moldawer, L. L., Fink, M. P., Andersson, U., Tracey, K. J., and Yang, H., Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol. Med., 9, 37-45 (2003).
42. Li, M., Carpio, D. F., Zheng, Y., Bruzzo, P., Singh, V., Ouaaz, F., Medzhitov, R. M., and Beg, A. A., An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol., 166, 7128-7135 (2001).
43. Liu, G., Wang, J., Park, Y. J., Tsuruta, Y., Lorne, E. F., Zhao, X., and Abraham, E., High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine. J. Immunol., 181, 4240-4246 (2008).
44. Liu, K., Mori, S., Takahashi, H. K., Tomono, Y., Wake, H., Kanke, T., Sato, Y., Hiraga, N., Adachi, N., Yoshino, T., and Nishibori, M., Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J., 21, 3904-3916 (2007).
45. Luster, A. D., Alon, R., and Von Andrian, U. H., Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol., 6, 1182-1190 (2005).
46. Mantell, L. L., Parrish, W. R., and Ulloa, L., Hmgb-1 as a therapeutic target for infectious and inflammatory disorders. Shock, 25, 4-11 (2006).
47. Messmer, D., Yang, H., Telusma, G., Knoll, F., Li, J., Messmer, B., Tracey, K. J., and Chiorazzi, N., High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J. Immunol., 173, 307- 313 (2004).
48. Nagayama, K., Iwamura, Y., Shibata, T., Hirayama, I., and Nakamura, T., Bactericidal activity of phlorotannins from the brown alga Ecklonia kurome. J. Antimicrob. Chemother., 50, 889-893 (2002).
49. Okada, Y., Ishimaru, A., Suzuki, R., and Okuyama, T., A new phloroglucinol derivative from the brown alga Eisenia bicyclis: potential for the effective treatment of diabetic complications. J. Nat. Prod., 67, 103-105 (2004).
50. Paonessa, G., Frank, R., and Cortese, R., Nucleotide sequence of rat liver HMG1 cDNA. Nucleic Acids Res., 15, 9077 (1987).
51. Park, J. S., Arcaroli, J., Yum, H. K., Yang, H., Wang, H., Yang, K. Y., Choe, K. H., Strassheim, D., Pitts, T. M., Tracey, K. J., and Abraham, E., Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell Physiol., 284, C870-C879 (2003).
52. Park, J. S., Gamboni-Robertson, F., He, Q., Svetkauskaite, D., Kim, J. Y., Strassheim, D., Sohn, J. W., Yamada, S., Maruyama, I., Banerjee, A., Ishizaka, A., and Abraham, E., High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. Cell Physiol., 290, C917- C924 (2006).
53. Park, J. S., Svetkauskaite, D., He, Q., Kim, J. Y., Strassheim, D., Ishizaka, A., and Abraham, E., Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem., 279, 7370-7377 (2004).
54. Passalacqua, M., Patrone, M., Picotti, G. B., Del Rio, M., Sparatore, B., Melloni, E., and Pontremoli, S., Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation. Neuroscience, 82, 1021-1028 (1998).
55. Pedrazzi, M., Patrone, M., Passalacqua, M., Ranzato, E., Colamassaro, D., Sparatore, B., Pontremoli, S., and Melloni, E., Selective proinflammatory activation of astrocytes by high-mobility group box 1 protein signaling. J. Immunol., 179, 8525-8532 (2007).
56. Qin, S., Wang, H., Yuan, R., Li, H., Ochani, M., Ochani, K., Rosas-Ballina, M., Czura, C. J., Huston, J. M., Miller, E., Lin, X., Sherry, B., Kumar, A., Larosa, G., Newman, W., Tracey, K. J., and Yang, H. Role of HMGB1 in apoptosismediated sepsis lethality. J. Exp. Med., 203, 1637-1642 (2006).
57. Sappington, P. L., Yang, R., Yang, H., Tracey, K. J., Delude, R. L., and Fink, M. P., HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology, 123, 790-802 (2002).
58. Scaffidi, P., Misteli, T., and Bianchi, M. E., Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature, 418, 191-195 (2002).
59. Serhan, C. N. and Savill, J., Resolution of inflammation: the beginning programs the end. Nat. Immunol., 6, 1191-1197 (2005).
60. Sha, Y., Zmijewski, J., Xu, Z., and Abraham, E., HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J. Immunol., 180, 2531-2537 (2008).
61. Sunden-Cullberg, J., Norrby-Teglund, A., Rouhiainen, A., Rauvala, H., Herman, G., Tracey, K. J., Lee, M. L., Andersson, J., Tokics, L., and Treutiger, C. J., Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit. Care Med., 33, 564-573 (2005).
62. Tian, J., Avalos, A. M., Mao, S. Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., Hua, J., An, L. L., Audoly, L., La Rosa, G., Bierhaus, A., Naworth, P., Marshak-Rothstein, A., Crow, M. K., Fitzgerald, K. A., Latz, E., Kiener, P. A., and Coyle, A. J., Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol., 8, 487-496 (2007).
63. Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., and Cerami, A., Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature, 330, 662-664 (1987).
64. Treutiger, C. J., Mullins, G. E., Johansson, A. S., Rouhiainen, A., Rauvala, H. M., Erlandsson-Harris, H., Andersson, U., Yang, H., Tracey, K. J., Andersson, J., and Palmblad, J. E., High mobility group 1 B-box mediates activation of human endothelium. J. Intern. Med., 254, 375-385 (2003).
65. Tsung, A., Klune, J. R., Zhang, X., Jeyabalan, G., Cao, Z., Peng, X., Stolz, D. B., Geller, D. A., Rosengart, M. R., and Billiar, T. R., HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J. Exp. Med., 204, 2913-2923 (2007a).
66. Tsung, A., Sahai, R., Tanaka, H., Nakao, A., Fink, M. P., Lotze, M. T., Yang, H., Li, J., Tracey, K. J., Geller, D. A., and Billiar, T. R., The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med., 201, 1135-1143 (2005).
67. Tsung, A., Zheng, N., Jeyabalan, G., Izuishi, K., Klune, J. R., Geller, D. A., Lotze, M. T., Lu, L., and Billiar, T. R., Increasing numbers of hepatic dendritic cells promote HMGB1- mediated ischemia-reperfusion injury. J. Leukoc. Biol., 81, 119-128 (2007b).
68. Ueno, H., Matsuda, T., Hashimoto, S., Amaya, F., Kitamura, Y., Tanaka, M., Kobayashi, A., Maruyama, I., Yamada, S., Hasegawa, N., Soejima, J., Koh, H., and Ishizaka, A., Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am. J. Respir. Crit. Care Med., 170, 1310-1316 (2004).
69. Urbonaviciute, V., Furnrohr, B. G., Meister, S., Munoz, L., Heyder, P., De Marchis, F., Bianchi, M. E., Kirschning, C., Wagner, H., Manfredi, A. A., Kalden, J. R., Schett, G., Rovere-Querini, P., Herrmann, M., and Voll, R. E., Induction of inflammatory and immune responses by HMGB1- nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med., 205, 3007-3018 (2008).
70. Van Zoelen, M. A., Laterre, P. F., Van Veen, S. Q., Van Till, J. W., Wittebole, X., Bresser, P., Tanck, M. W., Dugernier, T., Ishizaka, A., Boermeester, M. A., and Van Der Poll, T., Systemic and local high mobility group box 1 concentrations during severe infection. Crit. Care Med., 35, 2799- 2804 (2007).
71. Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., Manogue, K. R., Faist, E., Abraham, E., Andersson, J., Andersson, U., Molina, P. E., Abumrad, N. N., Sama, A., and Tracey, K. J., HMG-1 as a late mediator of endotoxin lethality in mice. Science, 285, 248-251 (1999a).
72. Wang, H., Vishnubhakat, J. M., Bloom, O., Zhang, M., Ombrellino, M., Sama, A., and Tracey, K. J., Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery, 126, 389-392 (1999b).
73. Wang, H., Ward, M. F., and Sama, A. E., Novel HMGB1- inhibiting therapeutic agents for experimental sepsis. Shock, 32, 348-357 (2009).
74. Wang, H., Yang, H., Czura, C. J., Sama, A. E., and Tracey, K. J., HMGB1 as a late mediator of lethal systemic inflammation. Am. J. Respir. Crit. Care Med., 164, 1768-1773 (2001).
75. Wang, H., Yang, H., and Tracey, K. J., Extracellular role of HMGB1 in inflammation and sepsis. J. Intern. Med., 255, 320-331 (2004).
76. Wang, H., Zhu, S., Zhou, R., Li, W., and Sama, A. E., Therapeutic potential of HMGB1-targeting agents in sepsis. Expert Rev. Mol. Med., 10, e32 (2008).
77. Wen, L., Huang, J. K., Johnson, B. H., and Reeck, G. R., A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1. Nucleic Acids Res., 17, 1197- 1214 (1989).
78. Wu, H., Chen, G., Wyburn, K. R., Yin, J., Bertolino, P., Eris, J. M., Alexander, S. I., Sharland, A. F., and Chadban, S. J., TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest., 117, 2847-2859 (2007a).
79. Wu, R., Dong, W., Cui, X., Zhou, M., Simms, H. H., Ravikumar, T. S., and Wang, P., Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann. Surg., 245, 480-486 (2007b).
80. Wu, R., Dong, W., Zhou, M., Zhang, F., Marini, C. P., Ravikumar, T. S., and Wang, P. Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am. J. Respir. Crit. Care Med., 176, 805-813 (2007c).
81. Yang, E. J., Lee, W., Ku, S. K., Song, K. S., and Bae, J. S., Anti-inflammatory activities of oleanolic acid on HMGB1 activated HUVECs. Food Chem. Toxicol., 50, 1288-1294 (2012).
82. Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., Diraimo, R., Czura, C. J., Roth, J., Warren, H. S., Fink, M. P., Fenton, M. J., Andersson, U., and Tracey, K. J., Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. U. S. A., 101, 296-301 (2004).
83. Yang, H., Wang, H., Czura, C. J., and Tracey, K. J., The cytokine activity of HMGB1. J. Leukoc. Biol., 78, 1-8 (2005).
84. Yang, H., Wang, H., and Tracey, K. J., HMG-1 rediscovered as a cytokine. Shock, 15, 247-253 (2001).
85. Yin, K., Gribbin, E., and Wang, H., Interferon-gamma inhibition attenuates lethality after cecal ligation and puncture in rats: implication of high mobility group box-1. Shock, 24, 396-401 (2005).
86. Youn, J. H. and Shin, J. S., Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J. Immunol., 177, 7889-7897 (2006).
87. Yu, M., Wang, H., Ding, A., Golenbock, D. T., Latz, E., Czura, C. J., Fenton, M. J., Tracey, K. J., and Yang, H., HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock, 26, 174-179 (2006).
88. Zhu, M., Chan, K. W., Ng, L. S., Chang, Q., Chang, S., and Li, R. C., Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J. Pharm. Pharmacol., 51, 175-180 (1999).